Delivery Order SPE2DB20D2104-SPE2DB23FU27J
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,561,545,800 units of the medication Escitalopram 10 mg tablets. The $1,697.83 firm fixed-price contract has a period of performance through July 20, 2023 and was not designated as a set-aside. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite...
- This federal contract award, valued at $1,457.38, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of 4,567,622,039 units of the pharmaceutical product Escitalopram 10 mg tablets. The contract has an ultimate completion date of March 20, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,849.52, is a delivery order for 4,563,081,478 units of the prescription medication Escitalopram 10 mg tablets. The contract has a completion date of December 13, 2023 and is a firm fixed-price contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,443,699 units of the medication Escitalopram 10 mg tablets. The $1,612.80 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.61 firm-fixed-price delivery order is for the supply of 4,558,009,304 tablets of 10 mg Escitalopram, a generic antidepressant medication. The contract has an ultimate completion date of August 8, 2022 and was awarded on August 5, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Escitalopram 10 mg tablets. The $2,767.45 firm fixed-price contract has a completion date of September 21, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award, valued at $2,552.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,828,520 tablets of the prescription medication Escitalopram 10 mg, with a completion date of March 4, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,101.64 fixed-price delivery order is for the supply of Escitalopram 10mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,034.80 firm fixed-price delivery order is for the supply of 1,000 tablets of the drug Escitalopram 10 mg. The contract has an ultimate completion date of April 7, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,635.38, is a delivery order for 4,562,280,822 units of the drug Escitalopram 10 mg tablets. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU27JDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,383.83 firm fixed-price delivery order is for the supply of 4,561,422,331 tablets of the pharmaceutical drug Escitalopram 10 mg. The contract has a period of performance through July 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veteran healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition. The contract represents Amerisourcebergen's continued role as a key vendor for essential pharmaceutical needs across various federal agencies and healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/6/23 |